Newer aspects of enzyme-linked immunosorbent assays
education. vol. 6. Basis for cancer therapy, part 2. Pergamon Press. New York. 8. Hollinshead, A. C., and T.H. M. Stewart. 1979. Lung tumor antigens: specific-active immunotherapy trials. pp. 1435-1463. In H. E. Nieburgs (ed.), Cancer detection and prevention. part 11. Marcel Dekker. Inc.• New York. 9. Hollinshead, A. C., T. H. M. Stewart, and H. Takita. 1979.Tumorassociated antigens: their usefulness as biological drugs. pp. 501-520. In Muggia and Rozcencweig(eds.), Lung cancer progress in therapeutic research. Raven Press, New York. 10. Krowlikowskl, F. J., K. Reuter, T. P. Waalkes, S. M. Siever, and R. H. Adamson. 1976.Serum sialic acid levels in lung cancer patients. Pharmacology 14:47-51. II. Mohr, J. A., R. E. Nordquist, E. R. Rhoades, R. E. Coalson, and J. J. Colson. 1974. Alveolar cell carcinoma-like antigen and antibodies in patients with alveolar cell carcinoma and other cancers. Cancer Res. 34: 1904-1907. 12. Sega, E., P. G. Natali, C. Ricci, C. T. Mineo, and G. Citro. 1974. Lung cancer tumor-associated antigens. Isolation by gel filtration. and characterization by immunodiffusion. Int. Rev. Cytol, [Suppl.) 2:1278. 13. Stewart, T. H. M., A C. Hollinshead, J. E. Harris, S. Raman, R. Belanger, A. Crepeau, A. F. Crook, W. E. Hirte, D. Hooper, D. J. Klaassen, E. F. Rapp, and H. J. Sachs. 1979. Specific-active immunochemotherapy in lung cancer: A survival study. pp. 278-285. In Bonnadona, Mathe and Salmon (eds.), Recent results in cancer research, vol. 68. Springer Verlag, Berlin. 14. Stewart, T. H. M., A. C. Hollinshead, andJ. E. Harris. 1976. Immunochemotherapy of lung cancer. Ann. NY Acad. Sci. 277:436-466. 15. Viza, D., M. Louvier, J. Phillips, C. Boucheix, and R. A. Guerin. 1975. Solubilization of an antigen associated with certain bronchial tumors. Eur. J. Cancer 11:765-770. 16. Yesner, R. 1978.Spectrum oflung cancer and ectopic hormones. Pathol. Annu.13:217-24O.